These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 2961562

  • 1. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR, Van Hoef B, Collen D.
    Eur J Biochem; 1987 Dec 01; 169(2):359-64. PubMed ID: 2961562
    [Abstract] [Full Text] [Related]

  • 2. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    Eur J Biochem; 1988 Nov 15; 177(3):575-82. PubMed ID: 2973984
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 4. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR.
    Biochemistry; 1998 May 19; 37(20):7231-6. PubMed ID: 9585535
    [Abstract] [Full Text] [Related]

  • 5. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR, Van Hoef B, Collen D.
    Biochim Biophys Acta; 1986 Dec 10; 884(3):402-8. PubMed ID: 3778931
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
    Lijnen HR, Li XK, Nelles L, Hu MH, Collen D.
    Eur J Biochem; 1992 Apr 15; 205(2):701-9. PubMed ID: 1533368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 12. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW, Ellis V, Dichek DA.
    J Biol Chem; 1994 Jan 28; 269(4):2411-8. PubMed ID: 8300567
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
    Lijnen HR, Van Hoef B, Nelles L, Collen D.
    J Biol Chem; 1990 Mar 25; 265(9):5232-6. PubMed ID: 1969415
    [Abstract] [Full Text] [Related]

  • 14. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
    Berkenpas MB, Quigley JP.
    Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7768-72. PubMed ID: 1652763
    [Abstract] [Full Text] [Related]

  • 15. Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Apr 25; 262(12):5682-9. PubMed ID: 3106341
    [Abstract] [Full Text] [Related]

  • 16. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB, Vasudevan J, Henkin J, Gonias SL.
    J Biol Chem; 1993 Aug 05; 268(22):16327-31. PubMed ID: 8393859
    [Abstract] [Full Text] [Related]

  • 17. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA, Nauland U, Dooijewaard G, Rijken DC.
    Thromb Haemost; 1996 Jun 05; 75(6):908-14. PubMed ID: 8822585
    [Abstract] [Full Text] [Related]

  • 18. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
    Li XK, Lijnen HR, Nelles L, Hu MH, Collen D.
    Biochim Biophys Acta; 1992 Sep 04; 1159(1):37-43. PubMed ID: 1390910
    [Abstract] [Full Text] [Related]

  • 19. Characterization of thrombin- and plasmin-resistant mutants of recombinant human single chain urokinase-type plasminogen activator.
    Eguchi Y, Sakata Y, Matsuda M, Osada H, Numao N, Ohmori M, Kondo K.
    J Biochem; 1990 Jul 04; 108(1):72-9. PubMed ID: 2146258
    [Abstract] [Full Text] [Related]

  • 20. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA, Collen A, Jie AF, Grimbergen JM, Rijken DC.
    Biochim Biophys Acta; 2000 Sep 20; 1497(3):351-8. PubMed ID: 10996659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.